Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 25, 2014
Efficient and allele-specific genome editing of disease loci in human iPSCsCory Smith, Leire Abalde-Atristain, Chaoxia He, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1991
The presence of cartilage matrix glycoprotein in serum as determined by immunolocation analysis is not a sensitive indicator of "early" osteoarthritis of the kneeR S Fife, K D Brandt, E M Braunstein, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2020
Ex vivo assays to detect complement activation in complementopathiesXuan Yuan, Jia Yu, Gloria Gerber, et al.
British Journal of Haematology|January 17, 2023
Characterization of myeloproliferative neoplasms in the paediatric and young adult populationZoey Harris, Hannah Kaizer, Aria Wei, et al.
Blood Advances|June 17, 2020
Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burdenTheodoros Karantanos, Shruti Chaturvedi, Evan M Braunstein, et al.
International Journal of Hematology|October 1, 2022
Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequencyMichael J Hochman, B Douglas Smith, Theodoros Karantanos, et al.
Blood Advances|March 8, 2021
Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndromeShruti Chaturvedi, Noor Dhaliwal, Sarah Hussain, et al.
Mbio|April 27, 2017
The EXIT Strategy: an Approach for Identifying Bacterial Proteins Exported during Host InfectionE F Perkowski, K E Zulauf, D Weerakoon, et al.
Plos One|April 26, 2017
A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC modelXuan Yuan, Zhe Li, Andrea C Baines, et al.
Clinical and Experimental Immunology|March 3, 2009
The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensisJ D Hall, S L Kurtz, N W Rigel, et al.
Pageof 17